XPO1 and breast carcinoma: Using publicly available XPO1 expression data and leptomycin B sensitivity information in a collection of breast cancer cell lines from the CCLE and CTRPv2, we performed a correlation analysis between XPO1 expression (at mRNA and protein level) and measured the cellular sensitivity to leptomycin B (Figure 3D,E).